IL1A and COVID-19: In addition, our observations suggest that IL-6 is probably not the only driving pathway of severe COVID-19 and that molecules upstream of IL-6 in the inflammatory cascade, such as IL-1, might represent more suitable targets to quench Sars-CoV-2 induced hyper-inflammation.